Royal Bank Of Canada Acer Therapeutics Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.57 - $1.28 $174 - $391	-306 Reduced 44.87%	376 $0
Q2 2023 Aug 14, 2023	BUY	$0.75 - $1.14 $511 - $777	682 New	682 $0
Q3 2022 Nov 14, 2022	BUY	$1.28 - $1.6 $16 - $20	13 New	13 $0
Q3 2021 Nov 15, 2021	SELL	$2.3 - $2.86 $229 - $286	-100 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.52 - $3.18 $252 - $318	100 New	100 $0

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.